A new method has been developed to make drugs 'smarter' using nanotechnology so they will be more effective at reaching their target. Scientists from the University of Lincoln, UK, have devised a new technique to 'decorate' gold nanoparticles with a protein of choice so they can be used to tailor drug to more accurately target an area on the body, such as a cancer tumour.
The new technology has been developed jointly by teams headed by Prof Dr Georg Schmitz at the Chair for Medical Engineering at Ruhr-Universität Bochum and by Prof Dr Fabian Kiessling at the Institute for Experimental Molecular Imaging at the University Hospital Aachen. They published their report in the journal Nature Communications from April 18, 2018.
From live-streaming funerals to online memorial pages and even chat-bots that use people's social media footprints' to act as online ghosts, the digital afterlife industry (DAI) has become big business. Our internet activity, commonly referred to as digital remains, lives on long after we die. In recent years, as firms such as Facebook and experimental start-ups have sought to monetize this content by allowing people to socialise with the dead online, the boundaries around acceptable afterlife activity and grief exploitation, have become increasingly blurry.
17 - 19 April 2018, Berlin, Germany.
How is the digitalisation of the healthcare system affecting the relationship between patients and doctors? What new innovations and solutions does the health IT industry have to offer? What new plans does the federal government have for eHealth? These are just some of the questions that conhIT - Connecting Healthcare IT will be asking in Berlin.
Researchers at the UCLA Samueli School of Engineering have demonstrated that deep learning, a powerful form of artificial intelligence, can discern and enhance microscopic details in photos taken by smartphones. The technique improves the resolution and color details of smartphone images so much that they approach the quality of images from laboratory-grade microscopes.
17 - 19 April 2018, Berlin, Germany.
Finding out about and supporting all aspects of the digital transformation of the healthcare system: that is what this year's conhIT, Europe's largest event for the health IT industry, is all about. From 17 to 19 April, in addition to the exhibitors who will present their products and solutions on the Berlin Exhibition Grounds, leading politicians, authors and experts will actively contribute to the debate on transforming healthcare.
The EU-funded network of digital innovation hubs DIATOMIC will distribute EUR 1.5 M to European SMEs, midcaps and Competence Centers. DIATOMIC is looking to accelerate development and adoption of new products/processes based on smart electronics and smart systems in health, agrifood, and manufacturing sectors. The call for applications is open from 15 March to 15 June.
The U.S. Food and Drug Administration today permitted marketing of the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy in adults who have diabetes. Diabetic retinopathy occurs when high levels of blood sugar lead to damage in the blood vessels of the retina, the light-sensitive tissue in the back of the eye.
For thousands of years, micro-organisms have been used to facilitate chemical reactions - in beer brewing, for example. However, biochemical processes are incredibly complex, with a multitude of reactions taking place simultaneously and influencing one another. There are countless parameters that play a role, not all of which can be directly measured.
For every two mobile apps released, one is a clone of an existing app. However, new research published in the INFORMS journal Information Systems Research shows the success of the original app is not always adversely affected by the creation of clone apps. In fact, the study, which was conducted by Carnegie Mellon University researchers, found that whether the copycat app increases or decreases the number of downloads of the original is dependent upon the quality of the copy.